Early experience with sirolimus in lung transplant recipients with chronic allograft rejection
- 1 February 2003
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 22 (2) , 169-176
- https://doi.org/10.1016/s1053-2498(02)00550-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Sirolimus: Continuing the Evolution of Transplant ImmunosuppressionAnnals of Pharmacotherapy, 2000
- Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre studyThe Lancet, 2000
- SDZ-RAD PREVENTS MANIFESTATION OF CHRONIC REJECTION IN RAT RENAL ALLOGRAFTSTransplantation, 2000
- Rapamycin Reverses Chronic Graft Vascular Disease in a Novel Cardiac Allograft ModelCirculation, 1999
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- SIROLIMUS: A POTENT NEW IMMUNOSUPPRESSANT FOR LIVER TRANSPLANTATIONTransplantation, 1999
- Lung transplantation.American Journal of Respiratory and Critical Care Medicine, 1997
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Bronchiolitis Obliterans in Recipients of Single, Double, and Heart-Lung TransplantationChest, 1995
- RISK FACTORS FOR OBLITERATIVE BRONCHIOLITIS IN HEART-LUNG TRANSPLANT RECIPIENTSTransplantation, 1991